News from nevro corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 18, 2015, 17:16 ET

Nevro Files S-1 Registration Statement for Proposed Primary and Secondary Public Offering

 Nevro Corp. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the...

May 11, 2015, 20:27 ET

Nevro Announces Filing of Petitions for Inter Partes Review of U.S. Patent No. 8,359,102

 Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform...

May 11, 2015, 07:30 ET

Nevro Reports First Quarter 2015 Financial Results

 Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform...

May 08, 2015, 22:38 ET

Nevro Receives FDA Approval for Senza® Spinal Cord Stimulation System Delivering HF10™ Therapy

Nevro Corp. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today...

Apr 28, 2015, 16:01 ET

Nevro to Report Operating Results for the First Quarter 2015

 Nevro Corp. (NYSE: NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation...

Mar 18, 2015, 16:02 ET

Nevro Reports Fourth Quarter and Full Year 2014 Financial Results

Nevro Corp. (NYSE: NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Mar 04, 2015, 16:01 ET

Nevro to Report Operating Results for the Fourth Quarter and Full Year of 2014

 Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation...

Mar 02, 2015, 16:05 ET

Nevro Appoints Dr. Brad Vale to its Board of Directors

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Feb 04, 2015, 16:01 ET

Nevro Receives Expanded MR-Conditional Labeling for Senza® Spinal Cord Stimulation System in Europe and Australia

 Nevro Corp. (NYSE: NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation...

Jan 28, 2015, 16:01 ET

Nevro to Present at the 2015 Leerink Global Healthcare Conference

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Jan 22, 2015, 19:30 ET

Nevro Receives Approvable Letter from U.S. Food and Drug Administration for Senza® Spinal Cord Stimulation System

 Nevro Corp. (NYSE: NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation...

Dec 29, 2014, 16:02 ET

Nevro to Present at the J.P. Morgan 33rd Annual Healthcare Conference

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Dec 15, 2014, 16:02 ET

Nevro Announces First Draw Down of $20 Million Under Term Loan Facility with CRG

 Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform...

Dec 02, 2014, 16:01 ET

Nevro Reports Third Quarter Financial Results

 Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform...

Nov 13, 2014, 16:02 ET

Nevro to Report 2014 Third Quarter Financial Results and Host Conference Call on December 2, 2014

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Nov 12, 2014, 11:43 ET

Nevro Corp. Announces Full Exercise of Over-Allotment Option and Closing of Initial Public Offering

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Nov 06, 2014, 00:43 ET

Nevro Corp. Announces Pricing of Initial Public Offering

Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for...

Mar 31, 2014, 05:47 ET

Nevro Strengthens Leadership Team with the Appointment of David Caraway, MD, PhD as Chief Medical Officer

Nevro, a growth stage medical device company focused on developing innovative, evidence based solutions in the neuromodulation space, announced...

Mar 11, 2014, 08:02 ET

Nevro Corp. Announces Publication of 24-month European Clinical Data on HF10 Spinal Cord Stimulation (SCS) Therapy for Chronic Back and Leg Pain

 Nevro Corp. announced today that the 24 month results of a prospective European clinical study using...

Feb 06, 2013, 03:05 ET

Nevro Corp. Announces Publication of Positive Six-Month Clinical Data for Senza® HF10™ High-Frequency Spinal Cord Stimulation Therapy in Europe

Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, today announced...